Zacks Investment Research on MSN
BD & Envetec showcase closed-loop recycling solution for lab plastics
Becton, Dickinson and Company BDX, popularly known as BD, recently announced the successful completion of a joint feasibility ...
Waters Corp. and BD announced a definitive agreement July 14 to combine BD’s Biosciences & Diagnostic Solutions businesses with the Milford, Mass.-based company. The deal is structured as a ...
BD is finalizing a February 5 spinoff, creating a $17.5B life sciences company with a $40B addressable market.
The president of BD’s life sciences division, Dave Hickey, is officially planning his retirement, with the calendar marked for July 1. Hickey has overseen BD’s portfolio of scientific research tools ...
Becton, Dickinson and Company BDX, popularly known as BD, is evaluating the divestment of its Life Sciences division as part of a broader strategic shift toward becoming a pure-play medtech company.
BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics, and the delivery of care. BD leads in patient and healthcare worker safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results